Skip to main content
. 2017 Nov 2;19(4):579–583. doi: 10.1007/s12017-017-8471-9

Fig. 1.

Fig. 1

Plasma levels of esRAGE (a) and sRAGE (b) in ischemic stroke patients with normal cognitive function (CDR = 0), mild cognitive impairment (CDR = 0.5), and dementia (CDR = 1). It showed that levels of esRAGE and sRAGE were significantly higher in ischemic stroke patients with dementia compared to those without dementia (both p < 0.001)